NEW YORK, June 22, 2016 /PRNewswire/ --
Growth is expected for the U.S. Medical Appliances and Equipment industry as demand for healthcare continues to rise. In today's pre-market research, Stock-Callers.com shifts its attention on these four equities for investors' close review: Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Amedica Corp. (NASDAQ: AMDA), and Nxstage Medical Inc. (NASDAQ: NXTM). Learn more about these stocks and receive your complimentary trade alerts at:
To access Stock-Callers.com full PDF Research Packages for free, please visit the links below.
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
ALGN Research Package: http://stock-callers.com/registration/?symbol=ALGN
ZLTQ Research Package: http://stock-callers.com/registration/?symbol=ZLTQ
AMDA Research Package: http://stock-callers.com/registration/?symbol=AMDA
NXTM Research Package: http://stock-callers.com/registration/?symbol=NXTM
At the close on Tuesday, shares in San Jose, California headquartered Align Technology Inc. saw a slight decline of 0.41%, ending the day at $79.34. The stock recorded a trading volume of 627,240 shares. The Company's shares have advanced 2.47% in the last one month, 13.64% in the previous three months, and 20.49% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 3.85% and 18.19%, respectively. Moreover, shares of Align Technology, which designs, manufactures, and markets a system of clear aligner therapy, intra-oral scanners, and computer-aided design and computer-aided manufacturing digital services for use in dentistry, orthodontics, and dental records storage globally, have a Relative Strength Index (RSI) of 58.82.
Shares in Pleasanton, California headquartered medical technology Company, ZELTIQ Aesthetics Inc. ended the day 2.52% lower at $27.06. A total volume of 744,216 shares was traded, which was above their three months average volume of 693,230 shares. In the last month and the previous three months, the stock has gained 7.21% and 8.81%, respectively. The Company's shares are trading below their 50-day moving average by 4.39%. Furthermore, shares of ZELTIQ Aesthetics, which engages in developing and commercializing non-invasive products for the selective reduction of fat, have an RSI of 40.72.
On Tuesday, shares in Salt Lake City, Utah headquartered commercial-stage biomaterial Company, Amedica Corp., finished flat at $1.26 and with a total volume of 169,192 shares traded. The stock is trading below its 50-day moving average by 14.59%. Shares of the Company, which develops, manufactures, and sells a range of medical devices based on its silicon nitride ceramic technology platform in the U.S., Europe, and South America, have an RSI of 36.15.
Lawrence, Massachusetts headquartered medical technology Company, Nxstage Medical Inc.'s shares recorded a trading volume of 539,041 shares at the end of yesterday's session and closed the day at $19.92, which was a slight drop of 0.05%. The stock has advanced 10.61% in the last one month and 35.97% in the previous three months. The Company's shares are trading above their 50-day and 200-day moving averages by 11.93% and 13.53%, respectively. Additionally, shares of Nxstage Medical, which develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure, have an RSI at 56.94.
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: email@example.com Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA